Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
HUMAN type-1 angiotensin II receptor (AGTR1) |
Target Info
|
Blocker |
[3], [4] |
| References |
Top |
| REF 1 |
FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 203867.
|
| REF 2 |
ClinicalTrials.gov (NCT04359953) Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19. U.S. National Institutes of Health.
|
| REF 3 |
Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic. Nat Rev Nephrol. 2020 Apr 3.
|
| REF 4 |
Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19. Drug Dev Res. 2020 May 1.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
